Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study Evaluating a New Radiation Treatment Workflow (NGDS)
- Where
- Cleveland, St Louis
- Age
- 21 years and over
- People
- 20
- Run by
- Varian, a Siemens Healthineers Company
See details and how to joinNCT07824583 - Phase 1/2Taking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Birmingham, Duarte, Goodyear, Houston, Nashville, New York, Pittsburgh, Zion
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - Phase 2Taking peopleHYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06858735 - Phase 2/3Taking peopleA Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
- Where
- Fairfax, Falls Church
- Age
- 18 years and over
- People
- 12
- Run by
- Inova Health Care Services
See details and how to joinNCT06007846 - No phaseTaking peopleEQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Where
- Cleveland
- Age
- 18 years and over
- People
- 200
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06263088 - Phase 1/2Not yet taking people in United StatesA Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC
- Where
- New York
- Age
- 18 years and over
- People
- 80
- Run by
- Zhejiang Haichang Biotech Co., Ltd.
See details and how to joinNCT07540832 - Phase 2Taking peopleDefining the Ablative Dose for Y-90 TARE
- Where
- Chicago
- Age
- 18 years and over
- People
- 30
- Run by
- Northwestern University
See details and how to joinNCT07586046 - Phase 1/2Taking peopleSafety of HRX215 in Patients After Minor and Major Liver Resection
- Where
- Baltimore, Cleveland, Durham, Rochester
- Age
- 18 years to 75 years
- People
- 80 worldwide
- Run by
- HepaRegeniX GmbH
See details and how to joinNCT06638502 - No phaseTaking peopleBiomarkers of Resiliency In Childhood Cancer Surgery
- Where
- Rochester
- Age
- 3 years to 25 years
- People
- 40
- Run by
- Mayo Clinic
See details and how to joinNCT06674811 - Phase 1/2Taking peopleGPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
- Where
- Buffalo, Dallas, Duarte, Portland, Seattle, The Bronx, Westwood
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Eureka Therapeutics Inc.
See details and how to joinNCT04864054 - Phase 2Taking peopleAlternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
- Where
- Columbus
- Age
- 18 years and over
- People
- 29
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07780838 - Phase 1Taking peopleSKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
- Where
- Glen Burnie, Pittsburgh
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SK Life Science, Inc.
See details and how to joinNCT07812805 - Phase 1Taking peopleA Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Where
- Fairfax, Houston, Los Angeles, Nashville, San Antonio, Sarasota, St Louis
- Age
- 18 years and over
- People
- 80
- Run by
- Angiex, Inc.
See details and how to joinNCT06440005 - Phase 1/2Taking peopleCTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06548412 - Phase 1/2Taking peopleSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Where
- Boston, Chicago, Detroit, Fairfax, Grand Junction, Houston, Lake Mary, Miami, Nashville, New York, Palo Alto, Salt Lake City, Urbana, Zion
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT05732831 - Phase 2Taking peopleTrial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
- Where
- New Haven
- Age
- 18 years to 80 years
- People
- 54
- Run by
- Yale University
See details and how to joinNCT07282912 - Phase 2Taking peopleAdjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
- Where
- Louisville
- Age
- 18 years and over
- People
- 315
- Run by
- Robert C. Martin
See details and how to joinNCT06526338 - Early phase 1Taking peopleTHIO and Cadonilimab in Resectable Hepatocellular Carcinoma
- Where
- Dallas
- Age
- 18 years and over
- People
- 60
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07446257 - Phase 2CompletedStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Abilene, Canton, Dallas, Denton, Detroit, Houston, La Jolla, Tampa
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - Phase 1/2Taking peopleA Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
- Where
- Birmingham
- Age
- 18 years and over
- People
- 45
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06294548 - Phase 1Not yet taking people in United StatesGI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy
- Where
- Chicago
- Age
- 18 years and over
- People
- 20
- Run by
- University of Illinois Chicago
See details and how to joinNCT07796997 - No phaseTaking peoplePilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Where
- Orange
- Age
- 18 years and over
- People
- 15
- Run by
- University of California, Irvine
See details and how to joinNCT05497531 - Early phase 1Not yet taking people in United StatesEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
- Where
- Boston, Grand Rapids, New York
- Age
- 18 years and over
- People
- 40
- Run by
- Lumina Pharmaceuticals Inc
See details and how to joinNCT07781852 - Phase 1/2Active, not recruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Boston, Canton, Cerritos, Chicago, Coral Springs, Covington, Dearborn, Fairfax, Honolulu, Houston, Lakeland, Lake Success, Laredo, Las Vegas, Los Angeles, Margate, Miami, Nashville, Newnan, New York, Oklahoma City, Philadelphia, Pittsburgh, Plantation, San Diego, Seattle, Shirley, Silver Spring, St Louis, Tamarac, Washington D.C., Wilson
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - Phase 1/2Taking peopleTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Chicago, Cincinnati, Houston, Indianapolis, Los Angeles, Memphis, Minneapolis, New York, Orange, Palo Alto, Philadelphia, Pittsburgh, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 12 months to 30 years
- People
- 147
- Run by
- Children's Oncology Group
See details and how to joinNCT04851119